PARP1 and metastatic malignant neoplasm in the lymph nodes: PARP1 expression was more frequent in the patients with higher tumor stage (P < 0.001), the presence of tumor invasion (P < 0.001), lymph node metastasis (P < 0.001), and venous invasion (P = 0.017).